Fibroblast growth-factor 23-Klotho axis is associated with systemic inflammation and myokine profile in children with chronic kidney disease

Karava V, Dotis J, Christoforidis A, Kondou A, Printza N (2020) Muscle-bone axis in children with chronic kidney disease: current knowledge and future perspectives. Pediatr Nephrol 36:3813–3327

Article  Google Scholar 

Sun DF, Chen Y, Rabkin R (2006) Work-induced changes in skeletal muscle IGF-1 and myostatin gene expression in uremia. Kidney Int 70:453–459

Article  CAS  PubMed  Google Scholar 

Bataille S, Chauveau P, Fouque D, Aparicio M, Koppe L (2021) Myostatin and muscle atrophy during chronic kidney disease. Nephrol Dial Transpl 36:1986–1993

Article  CAS  Google Scholar 

Karava V, Dotis J, Christoforidis A, Liakopoulos V, Kondou A, Tsigaras G, Tsioni K, Kollios K, Printza N (2021) Association between insulin growth factor-1, bone mineral density, and frailty phenotype in children with chronic kidney disease. Pediatr Nephrol 36:1861–1870

Article  PubMed  Google Scholar 

Karava V, Goutou S, Dotis J, Kondou A, Charela E, Dadoudi O, Eleftheriadis T, Stefanidis I, Printza N (2022) Fatigue and quality of life in children with chronic kidney disease. Child (Basel) 9:1414

Google Scholar 

Meza K, Biswas S, Zhu YS, Gajjar A, Perelstein E, Kumar J, Akchurin O (2021) Tumor necrosis factor-alpha is associated with mineral bone disorder and growth impairment in children with chronic kidney disease. Pediatr Nephrol 36:1579–1587

Article  PubMed  Google Scholar 

Yamamura-Miyazaki N, Michigami T, Ozono K, Yamamoto K, Hasuike Y (2022) Factors associated with 1-year changes in serum fibroblast growth factor 23 levels in pediatric patients with chronic kidney disease. Clin Exp Nephrol 26:1014–1021

Article  CAS  PubMed  Google Scholar 

Yamada S, Arase H, Yoshida H, Kitamura H, Tokumoto M, Taniguchi M, Hirakata H, Tsuruya K, Nakano T, Kitazono T (2022) Malnutrition-inflammation Complex Syndrome and Bone fractures and Cardiovascular Disease events in patients undergoing hemodialysis: the Q-Cohort study. Kidney Med 4:100408

Article  PubMed  PubMed Central  Google Scholar 

Yamada S, Tsuruya K, Kitazono T, Nakano T (2022) Emerging cross-talks between chronic kidney disease-mineral and bone disorder (CKD-MBD) and malnutrition-inflammation complex syndrome (MICS) in patients receiving dialysis. Clin Exp Nephrol 26:613–629

Article  CAS  PubMed  PubMed Central  Google Scholar 

Kuro-o M (2009) Klotho and aging. Biochim Biophys Acta 1790:1049–1058

Article  CAS  PubMed  PubMed Central  Google Scholar 

Prud’homme GJ, Kurt M, Wang Q (2022) Pathobiology of the Klotho Antiaging Protein and therapeutic considerations. Front Aging 3:931331

Article  PubMed  PubMed Central  Google Scholar 

Ewendt F, Feger M, Föller M (2021) Myostatin regulates the production of fibroblast growth factor 23 (FGF23) in UMR106 osteoblast-like cells. Pflugers Arch 473:969–976

Article  CAS  PubMed  PubMed Central  Google Scholar 

Bär L, Feger M, Fajol A, Klotz LO, Zeng S, Lang F, Hocher B, Föller M (2018) Insulin suppresses the production of fibroblast growth factor 23 (FGF23). Proc Natl Acad Sci U S A 115:5804–5809

Article  PubMed  PubMed Central  Google Scholar 

Rubinek T, Modan-Moses D (2016) Klotho and the growth Hormone/Insulin-Like Growth factor 1 Axis: Novel insights into Complex interactions. Vitam Horm 101:85–118

Article  CAS  PubMed  Google Scholar 

Ohsawa Y, Ohtsubo H, Munekane A, Ohkubo K, Murakami T, Fujino M, Nishimatsu SI, Hagiwara H, Nishimura H, Kaneko R, Suzuki T, Tatsumi R, Mizunoya W, Hinohara A, Fukunaga M, Sunada Y (2023) Circulating α-Klotho counteracts transforming growth Factor-β-Induced Sarcopenia. Am J Pathol 193:591–607

Article  CAS  PubMed  Google Scholar 

Wolf I, Shahmoon S, Ben Ami M, Levy-Shraga Y, Mazor-Aronovitch K, Pinhas-Hamiel O, Yeshayahu Y, Hemi R, Kanety H, Rubinek T, Modan-Moses D (2014) Association between decreased klotho blood levels and organic growth hormone deficiency in children with growth impairment. PLoS ONE 9:e107174

Article  PubMed  PubMed Central  Google Scholar 

Haffner D, Grund A, Leifheit-Nestler M (2021) Renal effects of growth hormone in health and in kidney disease. Pediatr Nephrol 36:2511–2530

Article  PubMed  PubMed Central  Google Scholar 

Schwartz GJ, Muñoz A, Schneider MF, Mak RH, Kaskel F, Warady BA, Furth SL (2009) New equations to estimate GFR in children with CKD. J Am Soc Nephrol 20:629–637

Article  PubMed  PubMed Central  Google Scholar 

Karava V, Kondou A, Dotis J, Taparkou A, Farmaki E, Kollios K, Printza N (2004) Exploring systemic inflammation in children with chronic kidney disease: correlates of interleukin 6. Pediatr Nephrol 39:1567–1576

Article  Google Scholar 

Choi SJ, Lee MS, Kang DH, Ko GJ, Lim HS, Yu BC, Park MY, Kim JK, Kim CH, Hwang SD, Kim JC, Won CW, An WS (2021) Myostatin/Appendicular Skeletal Muscle Mass (ASM) ratio, not myostatin, is Associated with Low Handgrip Strength in Community-Dwelling Older Women. Int J Environ Res Public Healt 18:7344

Article  CAS  Google Scholar 

David V, Martin A, Isakova T, Spaulding C, Qi L, Ramirez V, Zumbrennen-Bullough KB, Sun CC, Lin HY, Babitt JL, Wolf M (2016) Inflammation and functional iron deficiency regulate fibroblast growth factor 23 production. Kidney Int 89:135–146

Article  CAS  PubMed  PubMed Central  Google Scholar 

Egli-Spichtig D, Imenez Silva PH, Glaudemans B, Gehring N, Bettoni C, Zhang MYH, Pastor-Arroyo EM, Schönenberger D, Rajski M, Hoogewijs D, Knauf F, Misselwitz B, Frey-Wagner I, Rogler G, Ackermann D, Ponte B, Pruijm M, Leichtle A, Fiedler GM, Bochud M, Ballotta V, Hofmann S, Perwad F, Föller M, Lang F, Wenger RH, Frew I, Wagner CA (2019) Tumor necrosis factor stimulates fibroblast growth factor 23 levels in chronic kidney disease and non-renal inflammation. Kidney Int 96:890–905

Article  CAS  PubMed  Google Scholar 

Durlacher-Betzer K, Hassan A, Levi R, Axelrod J, Silver J, Naveh-Many T (2018) Interleukin-6 contributes to the increase in fibroblast growth factor 23 expression in acute and chronic kidney disease. Kidney Int 94:315–325

Article  CAS  PubMed  Google Scholar 

Munoz Mendoza J, Isakova T, Ricardo AC, Xie H, Navaneethan SD, Anderson AH, Bazzano LA, Xie D, Kretzler M, Nessel L, Hamm LL, Negrea L, Leonard MB, Raj D, Wolf M, Chronic Renal Insufficiency Cohort (2012) Fibroblast growth factor 23 and inflammation in CKD. Clin J Am Soc Nephrol 7:1155–1162

Article  PubMed  PubMed Central  Google Scholar 

Navarro-González JF, Mora-Fernández C, Muros M, Herrera H, García J (2009) Mineral metabolism and inflammation in chronic kidney Disease patients: a cross-sectional study. Clin J Am Soc Nephrol 4:1646–1654

Article  PubMed  PubMed Central  Google Scholar 

Zhao Y, Banerjee S, Dey N, LeJeune WS, Sarkar PS, Brobey R, Rosenblatt KP, Tilton RG, Choudhary S (2011) Klotho depletion contributes to increased inflammation in kidney of the db/db mouse model of diabetes via RelA (serine)536 phosphorylation. Diabetes 60:1907–1916

Article  CAS  PubMed  PubMed Central  Google Scholar 

Moreno JA, Izquierdo MC, Sanchez-Niño MD, Suárez-Alvarez B, Lopez-Larrea C, Jakubowski A, Blanco J, Ramirez R, Selgas R, Ruiz-Ortega M, Egido J, Ortiz A, Sanz AB (2011) The inflammatory cytokines TWEAK and TNFα reduce renal klotho expression through NFκB. J Am Soc Nephrol 22:1315–1325

Article  CAS  PubMed  PubMed Central  Google Scholar 

Oh HJ, Nam BY, Lee MJ, Kim CH, Koo HM, Doh FM, Han JH, Kim EJ, Han JS, Park JT, Yoo TH, Kang SW, Han DS, Han SH (2015) Decreased circulating klotho levels in patients undergoing dialysis and relationship to oxidative stress and inflammation. Perit Dial Int 35:43–51

Article  CAS  PubMed  PubMed Central  Google Scholar 

Lisowska KA, Storoniak H, Soroczyńska-Cybula M, Maziewski M, Dębska-Ślizień A (2022) Serum levels of α-Klotho, inflammation-related cytokines, and Mortality in Hemodialysis patients. J Clin Med 11:6518

Article  CAS  PubMed  PubMed Central 

留言 (0)

沒有登入
gif